Evaluation of Circulating MicroRNA Biomarkers in the Acute Pancreatic Injury Dog Model

Int J Mol Sci. 2018 Oct 6;19(10):3048. doi: 10.3390/ijms19103048.

Abstract

This study aimed to evaluate the usefulness of four microRNAs (miRNAs) in an acute pancreatic injury dog model. Acute pancreatitis was induced by infusion of cerulein for 2 h (7.5 μg/kg/h). The levels of well-known miRNAs, microRNA-216a (miR-216a) and microRNA-375 (miR-375), and new candidates microRNA-551b (miR-551b), and microRNA-7 (miR-7), were measured at 0, 0.5, 1, 2, 6, 12, and 24 h with serum amylase and lipase, and histopathological examination was performed. Among the four miRNAs, miR-216a and miR-375, and serum enzymes were significantly increased by cerulein treatment. The expression levels of miRNAs and serum enzymes peaked at 2⁻6 h with a similar pattern; however, the overall increases in miR-216a and miR-375 levels were much higher than those of the serum enzyme biomarkers. Increased levels of miR-216a and miR-375 were most highly correlated to the degree of individual histopathological injuries of the pancreas, and showed much greater dynamic response than serum enzyme biomarkers. Twenty-four-hour time-course analysis in this study revealed time-dependent changes of miRNA expression levels, from initial increase to decrease by predose level in acute pancreatitis. Our findings demonstrate that, in dogs, miR-216a and miR-375 have the potential to sensitively detect pancreatitis and reflect well the degree of pancreatic injury, whereas miR-551b and miR-7 do not.

Keywords: beagle dog; miRNA-216a; miRNA-375; miRNA-551b; miRNA-7; pancreatitis.

MeSH terms

  • Acute Disease
  • Amylases / blood
  • Animals
  • Biomarkers*
  • Circulating MicroRNA*
  • Disease Models, Animal
  • Dogs
  • Pancreas / metabolism
  • Pancreas / pathology
  • Pancreatitis / blood
  • Pancreatitis / diagnosis
  • Pancreatitis / genetics*
  • Severity of Illness Index
  • Time Factors

Substances

  • Biomarkers
  • Circulating MicroRNA
  • Amylases